1. Home
  2. CR vs BIO Comparison

CR vs BIO Comparison

Compare CR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CR
  • BIO
  • Stock Information
  • Founded
  • CR 1855
  • BIO 1952
  • Country
  • CR United States
  • BIO United States
  • Employees
  • CR N/A
  • BIO N/A
  • Industry
  • CR Metal Fabrications
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CR Industrials
  • BIO Industrials
  • Exchange
  • CR Nasdaq
  • BIO Nasdaq
  • Market Cap
  • CR 8.5B
  • BIO 8.7B
  • IPO Year
  • CR N/A
  • BIO N/A
  • Fundamental
  • Price
  • CR $147.08
  • BIO $316.54
  • Analyst Decision
  • CR Strong Buy
  • BIO Buy
  • Analyst Count
  • CR 6
  • BIO 4
  • Target Price
  • CR $164.00
  • BIO $369.00
  • AVG Volume (30 Days)
  • CR 154.3K
  • BIO 214.8K
  • Earning Date
  • CR 10-21-2024
  • BIO 10-24-2024
  • Dividend Yield
  • CR 0.57%
  • BIO N/A
  • EPS Growth
  • CR 25.57
  • BIO N/A
  • EPS
  • CR 4.15
  • BIO N/A
  • Revenue
  • CR $2,209,500,000.00
  • BIO $2,562,604,000.00
  • Revenue This Year
  • CR $79.54
  • BIO N/A
  • Revenue Next Year
  • CR N/A
  • BIO $4.49
  • P/E Ratio
  • CR $34.86
  • BIO N/A
  • Revenue Growth
  • CR 11.07
  • BIO N/A
  • 52 Week Low
  • CR $82.57
  • BIO $261.59
  • 52 Week High
  • CR $162.34
  • BIO $384.37
  • Technical
  • Relative Strength Index (RSI)
  • CR 43.74
  • BIO 48.90
  • Support Level
  • CR $141.19
  • BIO $319.01
  • Resistance Level
  • CR $145.89
  • BIO $337.50
  • Average True Range (ATR)
  • CR 3.52
  • BIO 8.23
  • MACD
  • CR -1.09
  • BIO -1.07
  • Stochastic Oscillator
  • CR 24.33
  • BIO 43.11

About CR Crane Company

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into three segments: aerospace and electronics, process flow technologies, and engineered materials. Crane generated approximately $2.1 billion in revenue in 2023.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: